Exploiting Atomic Force Spectroscopy To Assess Chemotherapeutic Drug Effects in Cancer Cells
Complete the form below to unlock access to ALL audio articles.
Oncotarget published "Dynamic cellular biomechanics in responses to chemotherapeutic drug in hypoxia probed by atomic force spectroscopy" which reported that by exploiting single-cell, force spectroscopy methods, the authors probed biophysical and biomechanical kinetics of brain, breast, prostate, and pancreatic cancer cells with standard chemotherapeutic drugs in normoxia and hypoxia over 12-24 hours.
After exposure to the drugs, they found that brain, breast, and pancreatic cancer cells became approximately 55-75% less stiff, while prostate cancer cells became more stiff, due to either drug-induced disruption or reinforcement of cytoskeletal structure.
However, the rate of the stiffness change decreased up to 2-folds in hypoxia, suggesting a correlation between cellular stiffness and drug resistance of cancer cells in hypoxic tumor microenvironment.
Also, they observed significant changes in the cell body height, surface roughness, and cytoadhesion of cancer cells after exposure to drugs, which followed the trend of stiffness.
These Oncotarget results show that a degree of chemotherapeutic drug effects on biomechanical and biophysical properties of cancer cells is distinguishable in normoxia and hypoxia, which are correlated with alteration of cytoskeletal structure and integrity during drug-induced apoptotic process.
Dr. Yongki Choi from The North Dakota State University said, "Cell surface plays important roles in fundamental cellular functions such as signaling, communication, adhesion, transport, and tumor metastasis"
The cell surfaces dynamically interact with physical, chemical, and biological environments surrounding cells and thus, alteration in cell's surface structure substantially influences overall cell functions.
In particular, deformability of cells associated with cell shape, motility, and invasion has shown implications for cell death and cancer metastasis, which is critical information for developing new anticancer drugs with increased efficacy in cancer chemotherapy.
While a number of studies have shown the relationship between chemotherapy-induced cell death and alteration in cellular mechanics such as stiffness, the impact of drugs on biomechanical and biophysical properties of cancer cells is not fully understood yet. Furthermore, stiffness at the tissue-level is significantly affected by the tumor stage, invasiveness, and location within the tumor due to the deposition of extracellular matrix, which influences the cellular behavior and metastatic capacity at the single-cell level as well.
Several studies using the AFM-based force measurements also have shown a significant change in cell stiffness with increasing metastatic efficiency in human cancer cell lines and chemotherapy exposure in leukemia cells.
In this work, these researchers quantified the drug effects on the biomechanical and biophysical properties of four cancer cell lines: MDA-MB-231 triple negative breast cancer, PANC-1 pancreatic cancer, PC-3 prostate cancer, and U-118 MG glioblastoma cell lines.
The Choi Research Team concluded in their Oncotarget Research Output that they have examined changes in biomechanical parameters of cancer cells exposed to an inhibitor of actin polymerization cytochalasin D in normoxia and hypoxia.
The PANC-1 cells became less stiff under increasing duration of exposure to cytochalasin D, and the decrease of stiffness was slower in hypoxia than normoxia.
Also, morphology and non-specific binding force measurements of the cells exposed to cytochalasin D showed a reduction in cell height and cellular adhesion, but an increase in cellular roughness.
Similar changes in biomechanical properties of other cancer cell lines treated with chemotherapeutic drugs and cytochalasin D suggest that the drug-induced cytotoxicity is partly due to dynamic changes in the cytoskeletal structure.
Although it is difficult to generalize drug effects on biomechanical and biophysical parameters of cancer cells, a combination of these parameters could help identify and distinguish the drug-induced apoptotic process in normoxia and hypoxia.
Reference: Alhalhooly L, Mamnoon B, Kim J, Mallik S, Choi Y. Dynamic cellular biomechanics in responses to chemotherapeutic drug in hypoxia probed by atomic force spectroscopy. Oncotarget. 2021;12(12):1165-1177. doi: 10.18632/oncotarget.27974
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.